Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | CHRM5 | P08912 | 10/20 | 0.40 |
| ▸ | CHRM3 | P20309 | 10/20 | 0.40 |
| ▸ | CHRM1 | P11229 | 9/20 | 0.40 |
| ▸ | CHRM2 | P08172 | 9/20 | 0.40 |
| ▸ | CHRM4 | P08173 | 9/20 | 0.40 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27635776 | 0.79 | MAPT (0.35) | POLBMAPTTDP1KMT2ANPSR1 | |
| SCHEMBL9828621 | 0.71 | CHRM5 (0.47) | POLBMAPTTDP1KMT2ANPSR1 | |
| SCHEMBL982856 | 0.71 | TSHR (0.46) | ALDH1A1KDM4EHPGDHSD17B10CA1 | |
| SCHEMBL7339250 | 0.71 | TSHR (0.46) | ALDH1A1KDM4EHPGDHSD17B10CA1 | |
| SCHEMBL9012682 | 0.71 | TSHR (0.46) | ALDH1A1KDM4EHPGDHSD17B10CA1 | |
| SCHEMBL3438539 | 0.69 | MAPT (0.61) | POLBMAPTTDP1KMT2ANPSR1 | |
| SCHEMBL11689734 | 0.69 | MAPT (0.46) | POLBMAPTTDP1KMT2ANPSR1 | |
| SCHEMBL434835 | 0.69 | — | — | |
| SCHEMBL1932849 | 0.68 | ESR2 (0.62) | — | |
| SCHEMBL1932846 | 0.68 | ESR2 (0.62) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1992009636-A1 | SKIN PROTECTIVE COMPOSITIONS AND METHOD OF INHIBITING SKIN IRRITATION | BAKER CUMMINS DERMATOLOGICALS, INC. (US) | 1992-06-11 | — | — | WO | disclosed |
| EP-0386219-A4 | METHOD OF TREATING INFLAMMATION IN MAMMALS UTILIZING KETOBUTYROLACTONES AND FURYLBUTYROLACTONES | — | 1991-11-13 | — | — | EP | disclosed |
| EP-0386219-A1 | METHOD OF TREATING INFLAMMATION IN MAMMALS UTILIZING KETOBUTYROLACTONES AND FURYLBUTYROLACTONES | THERACEL CORPORATION (US) | 1990-09-12 | — | — | EP | disclosed |
| EP-0386219-A1 | METHOD OF TREATING INFLAMMATION IN MAMMALS UTILIZING KETOBUTYROLACTONES AND FURYLBUTYROLACTONES | THERACEL CORPORATION (US) | 1990-09-12 | — | — | EP | disclosed |
| WO-1990001930-A1 | METHOD OF TREATING INFLAMMATION IN MAMMALS UTILIZING KETOBUTYROLACTONES AND FURYLBUTYROLACTONES | THERACEL CORPORATION (US) | 1990-03-08 | — | — | WO | disclosed |
| WO-1990001930-A1 | METHOD OF TREATING INFLAMMATION IN MAMMALS UTILIZING KETOBUTYROLACTONES AND FURYLBUTYROLACTONES | THERACEL CORPORATION (US) | 1990-03-08 | — | — | WO | disclosed |
| US-4883813-A | Method of treating inflammation in mammals utilizing ketobutyrolactones and furylbutyrolactones | AMERICAN BIOTECHNOLOGY COMPANY (US) | 1989-11-28 | — | — | US | disclosed |
| US-4883813-A | Method of treating inflammation in mammals utilizing ketobutyrolactones and furylbutyrolactones | AMERICAN BIOTECHNOLOGY COMPANY (US) | 1989-11-28 | — | — | US | disclosed |
| US-4883813-A | Method of treating inflammation in mammals utilizing ketobutyrolactones and furylbutyrolactones | AMERICAN BIOTECHNOLOGY COMPANY (US) | 1989-11-28 | — | — | US | disclosed |
| EP-0123446-B1 | 2-FURYLBUTYROLACTONE DERIVATIVES, THEIR PREPARATION, COMPOSITIONS CONTAINING THEM, AND THEIR USE FOR THE MODULATION OF THE IMMUNE SYSTEM IN MAMMALS | NATIONAL FOUNDATION FOR CANCER RESEARCH, INC. (US) | 1989-05-31 | — | — | EP | disclosed |
| EP-0123446-B1 | 2-FURYLBUTYROLACTONE DERIVATIVES, THEIR PREPARATION, COMPOSITIONS CONTAINING THEM, AND THEIR USE FOR THE MODULATION OF THE IMMUNE SYSTEM IN MAMMALS | NATIONAL FOUNDATION FOR CANCER RESEARCH, INC. (US) | 1989-05-31 | — | — | EP | disclosed |
| US-4620014-A | IMMUNOSUPPESSIVE AGENTS | NATIONAL FOUNDATION FOR CANCER RESEARCH (US) | 1986-10-28 | — | — | US | disclosed |
| US-4620014-A | IMMUNOSUPPESSIVE AGENTS | NATIONAL FOUNDATION FOR CANCER RESEARCH (US) | 1986-10-28 | — | — | US | disclosed |
| US-4518611-A | 2-Furylbutyrolactone modulation of the immune system in mammals | NATIONAL FOUNDATION FOR CANCER RESEARCH, INC. (US) | 1985-05-21 | — | — | US | disclosed |
| EP-0123446-A1 | 2-Furylbutyrolactone derivatives, their preparation, compositions containing them, and their use for the modulation of the immune system in mammals | NATIONAL FOUNDATION FOR CANCER RESEARCH, INC. (US) | 1984-10-31 | — | — | EP | disclosed |
| EP-0123446-A1 | 2-Furylbutyrolactone derivatives, their preparation, compositions containing them, and their use for the modulation of the immune system in mammals | NATIONAL FOUNDATION FOR CANCER RESEARCH, INC. (US) | 1984-10-31 | — | — | EP | disclosed |